Skip to content

Clinical trials

Phase 2 Spasm trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Spasm Phase: Phase 2 Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20072
20102
20123
20131
20173
20191
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Flex Pharma, Inc.2
Brlev Agricultural Crops Ltd1
Dalhousie University1
Enzymotec1
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.1
National Institute of Neurological Disorders and Stroke (NINDS)1
Neurana Pharmaceuticals, Inc.1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Rachel G. Greenberg, MD, MB, MHS1
Raymond Foster1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Spasm17
Attention Deficit Disorder with Hyperactivity7
Muscle Cramp3
Anxiety Disorders2
Nervous System Diseases2
Neurodegenerative Diseases2
Neuromuscular Diseases2
Acute Pain1
Amyotrophic Lateral Sclerosis1
Autism Spectrum Disorder1

Trials

Showing 51 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.